---
schema_version: "secwatch.filing_event.v1"
accession: "0000915779-24-000145"
form_type: "8-K"
ticker: "DAKT"
cik: "0000915779"
company_name: "DAKTRONICS INC /SD/"
filed_at: "2024-11-20T23:59:59+00:00"
generated_at: "2026-05-29T22:17:19.602803+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Daktronics extends poison pill, lowers trigger threshold to 15% amid dispute with Alta Fox

## Summary
- Board extended shareholder rights agreement to Nov 19, 2025; beneficial ownership trigger set at 15% (20% for passive investors).
- Exercise price per right changed to $40.00 under the amended rights agreement.
- Company to force conversion of $7M of Alta Fox's $25M convertible note into ~1.1M shares; Alta Fox threatened board nominations.
- Board rejected Alta Fox's demand for $79M to retire the note, citing best interests of common shareholders.

## SEC filing metadata
- accession: 0000915779-24-000145
- form_type: 8-K
- ticker: DAKT
- cik: 0000915779
- company_name: DAKTRONICS INC /SD/
- filed_at: 2024-11-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/915779/000091577924000145/0000915779-24-000145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/915779/000091577924000145/dakt-20241119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000915779-24-000145
- JSON: https://secwatch.observer/filing/0000915779-24-000145.json
- Plain text: https://secwatch.observer/filing/0000915779-24-000145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.